-
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
16 Jul 2025 13:00 GMT
… . Contacts Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris Wong Sing Ee
Chief Executive Officer
Email … : ir@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc …
-
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT
07 Jul 2025 10:00 GMT
… . Contacts Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris Wong Sing Ee
Chief Executive Officer
Email … : ir@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc …
-
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
03 Jun 2025 20:15 GMT
… contact: Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris Wong
Chief Executive Officer
Email … statements. © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved … trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
15 May 2025 04:50 GMT
… . Contacts Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris Wong Sing Ee
Chief Executive Officer
Tel … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc. CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
-
CYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLIT
07 May 2025 13:00 GMT
… . Contacts Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris Wong Sing Ee
Chief Executive Officer
Email … : ir@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc …
-
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE
06 May 2025 10:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, … contact: Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris Wong
Chief Executive Officer
Email … are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership
27 Feb 2025 18:38 GMT
… . 27, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ … ”) between Cyclacel’s former interim chief executive officer David Lazar (“Seller”) and … serve as Cyclacel’s next CEO,” said Datuk Dr. Doris Wong …
-
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
03 Jan 2025 14:01 GMT
… . 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP … down from his position as Chief Executive Officer of the Company and … Lazar was appointed as interim Chief Executive Officer. Dr. Kenneth Ferguson, Dr …
-
Why Cyclacel Pharmaceuticals (CYCC) Stock Is Skyrocketing
03 Jan 2025 15:31 GMT
Cyclacel Pharmaceuticals Inc CYCC shares are trading … assuming the role of interim CEO. Cyclacel also entered a Warrant … other instrument.
For example, in Cyclacel Pharmaceuticals’ case, it is in the …
-
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
12 Nov 2024 21:45 GMT
… ,” said Spiro Rombotis, President and Chief Executive Officer. “Nasdaq has granted the … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
About
© 1995-2026